tiprankstipranks
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market
SYRE
Spyre Therapeutics
RESEARCH TOOLSreports

Spyre Therapeutics (SYRE) Balance Sheet

525 Followers

Spyre Therapeutics Balance Sheet

Spyre Therapeutics's total assets for Q4 2025 were $777.78M, an increase of 54.14% from the previous quarter. SYRE total liabilities were $62.55M for the fiscal quarter, a 26.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 777.78M$ 608.48M$ 341.86M$ 71.14M$ 109.93M
Total Liabilities
$ 62.55M$ 90.68M$ 157.84M$ 20.84M$ 25.98M
Total Equity Gross Minority
$ 715.24M$ 517.80M$ 184.02M$ 50.30M$ 83.94M
Other Metrics
Currency in USD

Spyre Therapeutics Debt to Assets